Prolonged Glucosuria With Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Case Report and Review of Literature

Sodium-glucose cotransporter-2 (SGLT2) inhibitors assert their role as an anti-diabetic medication by reversibly inhibiting sodium-glucose cotransporters in the renal proximal tubules and resulting in enhanced glucose excretion. Due to their reversible effect on the transporters in the proximal tubu...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Ankita, Jain, Anubhav, Sachdeva, Sonali, Kulairi, Zain I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748582/
https://www.ncbi.nlm.nih.gov/pubmed/33365222
http://dx.doi.org/10.7759/cureus.11554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748582/
https://www.ncbi.nlm.nih.gov/pubmed/33365222
http://dx.doi.org/10.7759/cureus.11554

Ejemplares similares